Foodborne E coli infection

Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142-201.Full text  Abstract

Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004 Feb;2(2):123-40.Full text  Abstract

American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration; Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16;53(RR-4):1-33.Full text  Abstract

Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text  Abstract

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 2: preparing international travelers - travelers' diarrhea. May 2023 [internet publication].Full text

1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142-201.Full text  Abstract

2. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004 Feb;2(2):123-40.Full text  Abstract

3. Garcia-Aljaro C, Momba M, Muniesa M; Global Water Pathogen Project. Pathogenic members of Escherichia coli & Shigella spp. Shigellosis. August 2018 [internet publication].Full text

4. Orskov F, Orskov I. Escherichia coli serotyping and disease in man and animals. Can J Microbiol. 1992 Jul;38(7):699-704. Abstract

5. Marder EP, Griffin PM, Cieslak PR, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food: Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):324-8.Full text  Abstract

6. Ochoa TJ, Contreras CA. Enteropathogenic escherichia coli infection in children. Curr Opin Infect Dis. 2011 Oct;24(5):478-83. Abstract

7. Centers for Disease Control and Prevention. Notes from the field: enteropathogenic Escherichia coli outbreak at a child care center - Oregon, August 2021. Apr 2022 [internet publication].Full text

8. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009 Apr;80(4):609-14. Abstract

9. Khalil IA, Troeger C, Blacker BF, et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. Lancet Infect Dis. 2018 Nov;18(11):1229-40.Full text  Abstract

10. Ochoa TJ, Barletta F, Contreras C, et al. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008 Sep;102(9):852-6.Full text  Abstract

11. Tack DM, Kisselburgh HM, Richardson LC, et al. Shiga toxin-producing Escherichia coli outbreaks in the United States, 2010-2017. Microorganisms. 2021 Jul 17;9(7):1529.Full text  Abstract

12. Centers for Disease Control and Prevention. E. coli (Escherichia coli): questions and answers. Dec 2014 [internet publication].Full text

13. Centers for Disease Control and Prevention. Preliminary incidence and trends of infections caused by pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. Sites, 2022. Jun 2023 [[internet publication].Full text

14. Rangel JM, Sparling PH, Crowe C, et al. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis. 2005 Apr;11(4):603-9.Full text  Abstract

15. Centers for Disease Control and Prevention. Reports of Selected E. coli Outbreak Investigations. Oct 2022 [internet publication].Full text

16. UK Health Security Agency. Research and analysis: Escherichia coli (E. coli) O157: annual totals. Jun 2023 [internet publication].Full text

17. Meraz IM, Jiang ZD, Ericsson CD, et al. Enterotoxigenic Escherichia coli and diffusely adherent E coli as likely causes of a proportion of pathogen-negative travelers' diarrhea: a PCR-based study. J Travel Med. 2008 Nov-Dec;15(6):412-8.Full text  Abstract

18. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25.Full text  Abstract

19. Easton L. Escherichia coli O157: occurrence, transmission and laboratory detection. Br J Biomed Sci. 1997 Mar;54(1):57-64. Abstract

20. David ST, MacDougall L, Louie K, et al. Petting zoo-associated Escherichia coli O157:h7 - secondary transmission, asymptomatic infection, and prolonged shedding in the classroom. Can Commun Dis Rep. 2004 Oct 15;30(20):173-80. Abstract

21. Ojeniyi AA. Direct transmission of Escherichia coli from poultry to humans. Epidemiol Infect. 1989 Dec;103(3):513-22.Full text  Abstract

22. Damborg P, Nielsen SS, Guardabassi L. Escherichia coli shedding patterns in humans and dogs: insights into within-household transmission of phylotypes associated with urinary tract infections. Epidemiol Infect. 2009 Oct;137(10):1457-64. Abstract

23. Centers for Disease Control and Prevention. Notes from the field: an outbreak of Shiga toxin-producing Escherichia coli O157:H7 associated with a farming camp - Tennessee, 2022. Jul 2023 [internet publication].Full text

24. Erb A, Sturmer T, Marre R, et al. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):83-90. Abstract

25. White DG, Zhao S, Simjee S, et al. Antimicrobial resistance of foodborne pathogens. Microbes Infect. 2002 Apr;4(4):405-12. Abstract

26. European Centre for Disease Prevention and Control. Increase in Escherichia coli isolates carrying blaNDM-5 in the European union/European economic area, 2012-2022. May 2023 [internet publication].Full text

27. Day MJ, Hopkins KL, Wareham DW, et al. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet Infect Dis. 2019 Dec;19(12):1325-35.Full text  Abstract

28. Mengistu DA, Tolera ST. Prevalence of Microorganisms of Public Health Significance in Ready-to-Eat Foods Sold in Developing Countries: Systematic Review and Meta-Analysis. Int J Food Sci. 2020 Nov 2:8867250.Full text  Abstract

29. Käferstein FK, Motarjemi Y, Bettcher DW. Foodborne disease control: a transnational challenge. Emerg Infect Dis. 1997 Oct-Dec;3(4):503-10.Full text  Abstract

30. Schlundt J. New directions in foodborne disease prevention. Int J Food Microbiol. 2002 Sep 15;78(1-2):3-17. Abstract

31. American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration; Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16;53(RR-4):1-33.Full text  Abstract

32. Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl 1):S57-74.Full text  Abstract

33. Centers for Disease Control and Prevention. Guide to Confirming an Etiology in Foodborne Disease Outbreak. Oct 2015 [internet publication].Full text

34. Devleesschauwer B, Pires SM, Young I, et al. Associating sporadic, foodborne illness caused by Shiga toxin-producing Escherichia coli with specific foods: a systematic review and meta-analysis of case-control studies. Epidemiol Infect. 2019 Jul 8;147:e235.Full text  Abstract

35. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text  Abstract

36. Clark SD, Sidlak M, Mathers AJ, et al. Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing. Open Forum Infect Dis. 2019 Apr 16;6(4):ofz162.Full text  Abstract

37. Gould LH, Bopp C, Strockbine N, et al. Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep. 2009 Oct 16;58(RR-12):1-14.Full text  Abstract

38. Barcenas CH & Ibrahim NK. Chemotherapy–Induced Colitis. In: Fukata M, ed. Colitis. Croatia, Rijeka: InTech; 2012:115-18.

39. Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021 Feb 22;9(1):13-37.Full text  Abstract

40. British Columbia Ministry of Health; British Columbia Medical Association. Infectious diarrhea - guideline for investigation. Oct 2022 [internet publication].Full text

41. Public Health Agency of Canada. E. coli (Escherichia coli) infection. Oct 2021 [internet publication].Full text

42. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.Full text  Abstract

43. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med. 1999 Jun;106(6):670-6. Abstract

44. World Health Organization. Children: improving survival and well-being. Sep 2020 [internet publication].Full text

45. World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. Geneva: WHO Press; 2008.Full text

46. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med. 1993 Jun 10;328(23):1653-8.Full text  Abstract

47. Soriano-Brucher H, Avendano P, O'Ryan M, et al. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics. 1991 Jan;87(1):18-27. Abstract

48. Centers for Disease Control and Prevention. Enterotoxigenic E. coli (ETEC). Dec 2014 [internet publication].Full text

49. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 2: preparing international travelers - travelers' diarrhea. May 2023 [internet publication].Full text

50. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Full text

51. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930-1936. Abstract

52. Freedman SB, Xie J, Neufeld MS, et al. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis. 2016 May 15;62(10):1251-8.Full text  Abstract

53. Murphy GS, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med. 1993 Apr 15;118(8):582-6. Abstract

54. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. 21 March 2019 [internet publication].Full text

55. US Food & Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication]Full text

56. US Food & Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 20 Dec 2018 [internet publication].Full text

57. US Food & Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 12 May 2016 [internet publication].Full text

58. Sarker SA, Sultana S, Reuteler G, et al. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine. 2016 Feb;4:124-37.Full text  Abstract

59. Ahmed T, Bhuiyan TR, Zaman K, et al. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev. 2013 Jul 5;(7):CD009029.Full text  Abstract

60. Frenck RW Jr, Ervin J, Chu L, et al. Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. Lancet Infect Dis. 2019 Jun;19(6):631-40.Full text  Abstract

61. Farthing M, Salam MA, Lindberg G, et al. Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol. 2013 Jan;47(1):12-20.Full text  Abstract

62. Dundas S, Todd WT, Stewart AI, et al. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis. 2001 Oct 1;33(7):923-31.Full text  Abstract

63. Tserenpuntsag B, Chang HG, Smith PF, et al. Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis. 2005 Dec;11(12):1955-7.Full text  Abstract

64. Begue RE, Mehta DI, Blecker U. Escherichia coli and the hemolytic-uremic syndrome. South Med J. 1998 Sep;91(9):798-804. Abstract

65. World Health Organization. Factsheet: E. coli. February 2018 [internet publication].Full text

66. Imdad A, Mackoff SP, Urciuoli DM, et al. Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome. Cochrane Database Syst Rev. 2021 Jul 5;7(7):CD012997.Full text  Abstract

67. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007 Aug 15;26(4):535-44.Full text  Abstract

68. Acheson DW, Fiore AE. Preventing foodborne disease - what clinicians can do. N Engl J Med. 2004 Jan 29;350(5):437-40. Abstract